【レポートの概要（一部）】
1. Report Overview
1.1 Cell-Based Assays: Overview
1.2 Cell-Based Assays Market Segmentation
1.3 Why You Should Read This Report
1.4 How this Report Delivers
1.5 Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research and Analysis Methods
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Cell-Based Assays and Applications
2.1 Cost of New Drug Discovery and Development Reaches $2.6bn – Companies Constantly Looking for Increased Efficiencies
2.2 Drug Discovery Approaches- Target-Based and Phenotype-Based Discovery
2.3 Drug Screening Assays
2.4 Animal Models: In Vivo Conditions, but Results May Not Be Transferable to People
2.5 Biochemical Assays and their Advantages over Animal Models
2.5.1 Applications of Biochemical Assays
2.5.2 Lead Identification and Toxicity Testing
2.6 Cell-Based Assays and their Advantages
2.7 2D vs 3D Cell-Based Assays
2.8 The Different Assay Detection Methods and Technologies
2.9 Cells Used in Cell-Based Assays
2.9.1 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cells
2.9.2 Primary Cells: Closer to the In Vivo Environment, but Short Supply
2.9.3 Stem Cells: Potential to Overcome Limitations of Primary Cells and Immortalised Cell Lines
2.10 Uses for Cell-Based Assays in Drug Discovery and Development
2.10.1 Target Validation
2.10.2 Primary Screening
2.10.3 Secondary Screening
2.10.4 ADME Screening
2.10.5 High Throughput Screening: Greatly Increases Efficiency
3. World Cell-Based Assays Market, 2015-2025
3.1 Global Cell-Based Assays Market Forecast 2015-2025
3.2 Drivers for the Cell-Based Assays Market
3.3 Restraints for the Cell-Based Assays Market
3.4 Cell-Based Assays: Market Segments – Products and Services
3.5 Cell-Based Assays, Market Segments: Products Forecast 2015-2025
3.5.1 The Three Main Categories of Cell-Based Assay Products
3.5.1.1 Equipment Needed to Conduct Cell-Based Assays
3.5.1.2 Disposables Necessary to Perform Cell-Based Assays
3.5.1.3 Consumables Forming the Basis of Cell-Based Assays
3.6 Cell-Based Assays Market Segments: Services
3.6.1 Cell-Based Assays Market Segments: Services Forecast 2015-2025
3.7 Cell-Based Assays Market: Applications Forecasts 2015-2025
3.7.1 Drug Discovery Segment
3.7.2 ADME (Absorption, Distribution, Metabolism, Excretion) Segment
3.7.3 Basic Research Segment
4. Leading National Markets for Cell-Based Assays, 2015-2025
4.1 Regional Breakdown of the Global Cell-Based Assays Market, 2014 and 2025
4.2 Global Cell-Based Assays Market: Regional Forecast 2015-2025
4.3 The US Cell-Based Assays Revenue Forecast to 2025
4.4 European Union (EU) Cell-Based Assays Market 2015-2025
4.4.1 IMI’s Pan-European Drug Discovery Platform Holds Much Promise
4.4.2 EU Market: National Breakdown, 2014 and 2025
4.4.3 EU Market: Main National Forecasts 2015-2025
4.4.4 German Cell-Based Assay Revenue Forecast to 2025
4.4.5 French Cell-Based Assays Revenue Forecast to 2025
4.4.6 UK Cell-Based Assays Revenue Forecast to 2025
4.4.7 Spanish Cell-Based Assays Revenue Forecast to 2025
4.4.8 Italian Cell-Based Assays Revenue Forecast to 2025
4.5 Japanese Cell-Based Assays Revenue Forecast to 2025
4.6 BRIC Nations (Brazil, Russia, India, China) Cell-Based Assays Market
4.6.1 BRIC Countries: National Breakdown 2014 and 2015
4.6.2 BRIC Countries: National Forecasts 2015-2025
4.6.3 Chinese Cell-Based Assay Revenue Forecast to 2025
4.6.4 Indian Cell-Based Assays Revenue Forecast to 2025
4.6.5 Russian Cell-Based Assays Revenue Forecast to 2025
4.6.6 Brazilian Cell-Based Assays Revenue Forecast to 2025
5. Companies in the Cell-Based Assays Market: Product Suppliers, 2015
5.1 Thermo Fisher Scientific
5.1.1 Cell-Based Assay Technologies under the Life Technologies Business Unit – Over 300 Products Offered
5.1.2 Also Offers Custom Assays, Related Products and HCA Products
5.2 DiscoveRx
5.2.1 PathHunter Technology
5.2.2 Other Assay Platforms and Drug Discovery Services
5.3 PerkinElmer
5.3.1 AlphaScreen Technology
5.3.2 DELFIA TRF Assays
5.3.3 Label-Free Cellular Assay Detection, and the Opera System
5.4 BD (Becton, Dickinson and Company)
5.4.1 Cell-Based Assays Through BD Life Sciences
5.5 InSphero
5.5.1 GravityPLUS- Leading Solution for 3D Cell-Based Assays
5.6 Biocroi
5.6.1 The Technology Behind and the Advantages of Happy Cell ASM and its 3D Cell Culture
5.7 GE Healthcare
5.7.1 Cell-Based Assays Through GE Healthcare Life Sciences
5.8 Molecular Devices
5.8.1 Cell-Based Assay Products Include SpectraMax Microplate Readers and FLIPR Tetra System
5.9 Promega
5.9.1 Assays Range from Cell Viability Assays to Mitochondrial Function Assays
5.10 BioVision
5.10.1 Cell-Based Assays Include the EZCell Platform and a Cholesterol Detection Kit
6. Companies in the Cell-Based Assays Market: CROs and Service Providers, 2015
6.1 Fluofarma
6.1.1 Over 100 Cell-Based Assays, and Partnership with Harlan
6.2 CYTOO
6.2.1 Cell Micropatterning to Eliminate Trade-Off between Quantity and Quality?
6.2.2 Cell-Based Assays for Muscular Atrophy / Hypertrophy and Anti-Cancer Drug Profiling
6.3 Cell Assay Innovations (CAI)
6.3.1 ClariCELL Technology
6.4 ProQinase
6.4.1 Various Cell-Based Assays for Characterising Anti-Cancer Compounds
6.5 Charles River Laboratories
6.5.1 PhenoFocus – Portfolio of over 100 Primary Cell-Based Assays
6.6 SGS
6.6.1 Offers a Range of Services, Including 3D Cell-Based Assays
6.7 Pharmaceutical Product Development (PPD)
6.8 Marin Biologic Laboratories
7. Cell-Based Assays Technology, Trends and Future Outlook
7.1 Stem Cells: Vast Potential
7.1.1 The Benefits of using Stem Cells in Cell-Based Assays
7.1.2 IPSCs: An Uncontroversial and Abundant Source
7.1.3 Companies Providing Stem Cell-Based Assays
7.2 Toxicity Testing: Important Field for Cell-Based Assays
7.3 3D Systems: The Advantages of these Next Generation Cell Systems
7.3.1 Complexity of 3D Systems is a Challenge, but More and More are Gradually Reaching the Market
7.4 Increasing Outsourcing of Cell-Based Assays
7.5 Label-Free Technology
7.6 GPCRs: A Common Drug and Drug Discovery Target
7.6.1 GPCRs in Cell-Based Assays
7.6.2 Allosteric GPCRs
7.7 Increasing Miniaturisation and Automation
7.7.1 Advantages of Miniaturisation
7.7.2 Advantages of Automation
7.8 Microfluidics- Set to be a Trend
7.8.1 Can Mimic the In Vivo Environment
7.8.2 The Potential and the Challenges
7.9 Multiplexing: Improves Efficiency of Cell-Based Assays
7.9.1 Advantages will Drive Growth
7.10 High Content Screening: A Well Established Tool
7.10.1 The Future for HCS: Will Continue to Expand, Still Room for Innovation
7.11 Cell-Based Assays in Biologics Development
8. Qualitative Analysis of the Cell-Based Assays Market, 2015
8.1 SWOT Analysis of the Cell-Based Assays Market
8.1.1 Strengths Within the Cell-Based Assays Market
8.1.2 Weaknesses Within the Cell-Based Assays Market
8.1.3 Opportunities for the Cell-Based Assays Market
8.1.4 Threats to the Cell-Based Assays Market
8.2 STEP Analysis of the Cell-Based Assays Market
8.2.1 Social Factors
8.2.2 Technological Factors
8.2.3 Economic Factors
8.2.4 Political Factors
9. Research Interviews
9.1 Interview with Luc Selig, Chief Business Officer at CYTOO
9.1.1 CYTOO’s Definition a Cell-Based Assay, and the Cell-Based Assay Market
9.1.2 The Advantages of CYTOO’s Products and Services
9.1.3 Thoughts on the Competition Within the Cell-Based Assays Market
9.1.4 Revenue Expectations, Company Focus and the Future of the Cell-Based Assay Market
9.1.5 On Challenges for the Industry and Cell-Based Assays vs Animal Models
9.2 Interview with Molecular Devices
9.2.1 Molecular Devices’ Definition of the Market
9.2.2 On Molecular Devices’ Most Well-Known Products, and their Advantages
9.2.3 On the Future of the Cell-Based Assays Market
9.2.4 Opportunities and Challenges for the Market, and the Competition Within it
9.3 Interview with Deborah Moshinsky, President and CEO of Cell Assay Innovations (CAI)
9.3.1 On the Challenges of Developing a Cell-Based Assay
9.3.2 On ClariCELL Technology and its Advantages
9.3.3 Competition in the Cell-Based Assays Market and Future Perspectives
10. Conclusions from the Research and Analysis
10.1 Growth Has Been Driven by Advantages of Cell-Based Assays
10.2 Current Status of the Market and its Growth Drivers
10.3 The Most Dominant National Markets and Emerging Countries
10.4 Future Trends and Technology
【レポート販売概要】
■ タイトル：セルベースアッセイの世界市場：セルベースアッセイ装置/消耗品/サービス■ 英文：Cell-Based Assays: World Industry and Market Prospects 2015-2025
■ 発行日：2015年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN5050808
■ 調査対象地域：グローバル
- 血管閉鎖デバイスの世界市場予測（～2022年）：コラーゲンプラグ、密閉剤/ゲル、クリップ、縫合装置The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for the market include a large number of approvals for vascular closure devices, increasing focus of market players on large-bore vascular closure devices, the high prevalence of cardiovascular diseases, and high prevalence of obesity. On th …
- 心臓POC試験装置の世界市場2019-2023Global Cardiac POC Testing Devices Market: About this market Cardiac POC testing devices aid in the assessment of glucose and cholesterol levels in individuals, which in turn help the practitioners to identify the risk of developing thrombosis and cardiovascular diseases (CVDs) such as coronary artery disease (CAD), myocardial infarction and heart failure. Technavio’s cardiac POC testing devices m …
- リニアポリエチレン(LLDPE)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world polyethylene linear low density market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all togeth …
- 急性骨髄性白血病（AML）治療薬の世界市場2015-2019About Acute Myeloid Leukemia Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor cells. Neoplasms arise from bone marrow, however, it spreads quickly into the blood. In the later stages of the disorder, it spreads to spleen, lymph node, liver, brain, spinal cord and testicles. Cl …
- 注入ポンプの世界市場：インスリンポンプ、経腸供給ポンプ、その他A Strong Infusion pumps pipeline –Will it have a significant effect on the market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there. Included in the report is a lengthy discussion of the strengths and weakness of the field of infusion pumps, as well as the opportunities and threats facing developers. The report includes a …
- 可変周波数駆動(VFD)の世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Variable Frequency Drives (VFD) Market 2019-2023 Technavio recognizes the following companies as the key players in the global variable frequency drives (VFD) market: ABB, Danfoss, Rockwell Automation Inc., Schneider Electric, Siemens. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momen …
- オーソバイオロジクスの世界市場：幹細胞、骨誘導因子、合成移植骨、関節保護薬、骨基質、同種移植片About Orthobiologics Orthobiologics is an advancing medical field that involves the use of biomaterials and cell-based therapies to repair broken bones, prevent bone degeneration, and provide bone stability. Orthobiologic products are obtained from naturally occurring materials. These products help treat people with long-term disabling musculoskeletal disorders and injuries. Innovations in orthobi …
- 小売りにおけるビックデータ（Big Data in Retail）The retail industry represents a large portion of the world economy, consists of a large ecosystem, and has experienced some significant challenges and opportunities in recent years. One rather significant issue is the so called “Showrooming” in which consumers test/compare products and buy them elsewhere. This is a particular problem for Big Box stores that display consumer electronics, major app …
- 活性アルミナの世界市場2016-2020About Activated Alumina Activated alumina is a highly porous material produced by the dehydroxylation of aluminum hydroxide. The compound has a high surface-to-weight ratio with a surface area between 120 and 250 square meters per gram of the raw material. It does not soften or disintegrate when immersed in liquids. Activated alumina is good packing media and is used as an air and gas desiccant, d …
- 美容整形外科の世界市場2016-2020About Cosmetic Surgery Cosmetic surgery is a procedure carried out to improve the appearance of specific parts of the body. Both men and women may opt for these surgeries, and they are usually carried out over areas which are otherwise functioning perfectly. Cosmetic surgery is elective in nature and falls outside the purview of medical reimbursements. Technavio’s analysts forecast the global cosm …
- 板金装置の世界市場：金属切削装置、金属成形装置、溶接装置About Sheet Metals Sheet metals are created with the help of an industrial process that turns metals, such as brass, copper aluminum, steel, titanium, tin, and nickel, into thin and flat pieces. Sheet metals are one of the basic metal forms used in the metal fabrication industry. Technavio’s analysts forecast the global sheet metal equipment market to grow at a CAGR of 6.69% during the period 2016 …
- ビジネスジェットの世界市場予測（～2030年）An increasing number of high net worth individuals is one of the significant factors driving the business jets market The business jets market is projected to grow from an estimated USD 24.7 billion in 2019 to USD 36.4 billion by 2030, at a CAGR of 3.6% during the forecast period. Besides an increasing number of high net worth individuals, aging fleet size and upcoming new aircraft programs are ex …
- Kableの市場機会・予測（～2018）レポート：企業アプリケーションProduct Synopsis Kable's Market Opportunity Forecast outlines the primary findings from our ongoing research into the dynamics in the Enterprise Applications market. Introduction and Landscape This product provides revenue opportunity forecasts in the Enterprise Applications market from 2014 to 2018, spanning eight technology segments, 37 geographical markets, six regions, 14 verticals, two size b …
- HIV-2感染症(HIV-2 Infection)：世界の治験レビュー2014年下半期版HIV-2 Infection Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “HIV-2 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-2 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-2 Infection. It includes an overview of the trial numbers and their recruitment status as …
- 軍隊プラットフォーム支援サービスの世界市場Military platforms form the basis of the ability of states to conduct military activities in the modern world. Used to combat adversaries, these assets also serve to coerce potential enemies through the threat of force or the demonstration of would-be combat. Similarly, military platforms are used to deter aggression from adversaries through the demonstration of military capability – and thus abil …
